Eli Lilly licenses non opioid pain med for $40M upfront

cafead

Administrator
Staff member
  • cafead   Mar 02, 2023 at 10:02: AM
via Belgium-based Confo Therapeutics announced a licensing agreement with Eli Lilly (NYSE:LLY) on Wednesday to grant the pharma giant global rights for its experimental non-opioid pain therapy CFTX-1554 for $40M upfront.

article source
 

<